Literature DB >> 1850190

Molecular analyses of an acidic transthyretin Asn 90 variant.

M J Saraiva1, M R Almeida, I L Alves, P Moreira, M Gawinowicz, P P Costa, S Rauh, A Banhzoff, K Altland.   

Abstract

A mutation in transthyretin (TTR Asn 90) has been identified in the Portuguese and German populations. This variant has a lower pI and was found by screening analyses in 2/4,000 German subjects and in 4/1,200 Portuguese by using either double one-dimensional (D1-D) electrophoresis with isoelectric focusing (IEF) or hybrid isoelectric focusing in immobilized pH gradient (HIEF) as the final separation step. The Portuguese population sample was from the area where TTR Met 30-associated familial amyloidotic polyneuropathy (FAP) prevails, and it was divided into (a) a group of 500 individuals belonging to FAP kindreds and (b) a group of 700 collected at random. HIEF showed two particular situations: (1) one case, from an FAP kindred, was simultaneously carrier of the Met 30 substitution and the acidic variant, and (2) one individual, from the randomly selected Portuguese sample, had only the acidic monomer. Comparative peptide mapping, by HPLC, of the acidic variant carriers and of normal TTR showed the presence of an abnormal tryptic peptide, not present in the normal TTR digests, with an asparagine-for-histidine substitution at position 90 explained by a single base change of adenine for cytosine in the histidine codon. This was confirmed at the DNA level by RFLP analyses of PCR-amplified material after digestion with SphI and BsmI. In all carriers of the Asn 90 substitution, no indicators were found for an association with traits characteristic for FAP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850190      PMCID: PMC1683057     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  3 in total

1.  Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant.

Authors:  M J Saraiva; W Sherman; C Marboe; A Figueira; P Costa; A F de Freitas; M A Gawinowicz
Journal:  Scand J Immunol       Date:  1990-10       Impact factor: 3.487

2.  Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30.

Authors:  M R Almeida; I L Alves; Y Sakaki; P P Costa; M J Saraiva
Journal:  Hum Genet       Date:  1990-10       Impact factor: 4.132

3.  A new mutation causing familial amyloidotic polyneuropathy.

Authors:  J C Skare; M J Saraiva; I L Alves; I B Skare; A Milunsky; A S Cohen; M Skinner
Journal:  Biochem Biophys Res Commun       Date:  1989-11-15       Impact factor: 3.575

  3 in total
  5 in total

1.  Detection of transthyretin variants using immunoprecipitation and matrix-assisted laser desorption/ionization bioreactive probes: a clinical application of mass spectrometry.

Authors:  R Théberge; L H Connors; M Skinner; C E Costello
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.109

2.  Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Authors:  K Li; R A Kyle; P J Dyck
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Transthyretin Ser 6 gene frequency in individuals without amyloidosis.

Authors:  D R Jacobson; I L Alves; M J Saraiva; S N Thibodeau; J N Buxbaum
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

4.  Haplotype analysis of common transthyretin mutations.

Authors:  M R Almeida; N Aoyama-Oishi; Y Sakaki; G Holmgren; D Ulf; A Ferlini; F Salvi; M Munar-Oués; M D Benson; M Skinner
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

5.  Structure of Met30 variant of transthyretin and its amyloidogenic implications.

Authors:  C J Terry; A M Damas; P Oliveira; M J Saraiva; I L Alves; P P Costa; P M Matias; Y Sakaki; C C Blake
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.